Background: Starting from 2018 onwards, several outbreaks of fluconazole‐resistant C. parapsilosis have been reported in many countries worldwide.Objectives: Here we report a retrospective study on C. parapsilosis blood isolates collected over 7 years (2018–2024) in two hospitals in Northern Italy.Patients/Methods: The study involved 169 C. parapsilosis isolates collected from individual hospitalised patients. We assessed the antifungal susceptibility of the isolates, evaluated the presence of mutations in the ERG11 gene and performed multilocus microsatellite typing to highlight the genetic relatedness of the strains. All isolates were also tested for their ability to produce biofilm.Results: Among the 169 clinical isolates, 124 (73.4%) were classified as fluconazole‐resistant C. parapsilosis (FRCP) and 45 (26.6%) as fluconazole‐susceptible (FSCP). ERG11 sequencing highlighted that the most frequent mutation in FRCP is the Y132F (118/124, 95.2%). None of the FSCP carried the Y132F. Microsatellite genotyping showed five major clusters and 13 sub‐clusters, formed by isolates sharing identical genotypes. Sub‐cluster R1 included 96 FRCP carrying the Y132F substitution, isolated from 2018 to 2024 in both hospitals. Interestingly, 99.1% of the FRCP carrying the Y132F mutation were categorised as low biofilm formers, while FRCP carrying other ERG11 mutations were categorised as medium or high biofilm formers.Conclusions: Our results confirmed that Y132F may be mainly responsible for azole resistance in C. parapsilosis and inter‐hospital spread. As we found, recent clinical studies indicate that FRCP isolates responsible for severe outbreaks produce thin biofilms. Mutated and therefore resistant strains may exhibit reduced biofilm production as a protective mechanism.
The clinical cases described in this text add to the limited literature on chronic and allergic rhinosinusitis caused by dematiaceous fungi, particularly Curvularia spicifera. These cases highlight the growing recognition of fungal infections as a significant factor in the etiology of rhinosinusitis, a condition traditionally attributed to bacterial causes It has become evident that a comprehensive clinical approach, involving diagnostic imaging and laboratory examinations, particularly culture-based analysis, has been crucial in identifying the specific fungal pathogen responsible for the infection. Additionally, molecular biology techniques have proven indispensable in enhancing diagnostic accuracy and the understanding of such infections. Importantly, these types of infections are commonly observed in immunocompetent individuals, distinguishing them from other fungal infections that typically affect immunocompromised patients. This study underlines the importance of integrating microbiological findings with clinical, radiological, and histopathological data for the accurate diagnosis of non-invasive fungal rhinosinusitis, particularly given the lack of serological assays specific for this species. The available literature on these infections remains limited, and diagnosis continues to rely on an integrated multimodal approach.
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is the etiologic agent that causes the coronavirus disease (COVID-19) identified in Wuhan, in 2019. Men are more prone to developing severe manifestations than women, suggesting a possible crucial role of sex hormones. 17,β-Estradiol (E2) and 1,25 α dihydroxyvitamin D3 (calcitriol) act upon gene pathways as immunomodulators in several infectious respiratory diseases. In this study, we aimed to evaluate the influence of E2 and calcitriol on the VSV-based pseudovirus SARS-CoV-2 and SARS-CoV-2 infection in vitro. We infected Vero E6 cells with the recombinant VSV-based pseudovirus SARS-CoV-2 and the SARS-CoV-2 viruses according to the pre-treatment and pre–post-treatment models. The Angiotensin-Converting Enzyme 2 (ACE2) and Vitamin D Receptor (VDR) gene expression did not change under different treatments. The VSV-based pseudovirus SARS-CoV-2 infection showed a significant decrease in the focus-forming unit count in the presence of E2 and calcitriol (either alone or in combination) in the pre-treatment model, while in the pre–post-treatment model, the infection was inhibited only in the presence of E2. Th SARS-CoV-2 infection highlighted a decrease in viral titres in the presence of E2 and calcitriol only in the pre–post-treatment model. 17,β-Estradiol and calcitriol can exert an inhibitory effect on SARS-CoV-2 infections, demonstrating their protective role against viral infections.
The emergence of drug-resistant cytomegalovirus (CMV) complicates viral response to therapy. We present two cases of solid organ transplant (SOT) recipients, highlighting the reversion of UL97 mutations associated with val(ganciclovir) resistance. Patient 1, a heart transplant recipient, initially received pre-emptive treatment with val(ganciclovir), followed by foscarnet for recurrent CMV episodes. Mutations A594V in the UL97-kinase gene and V715M in the UL54-polymerase gene were detected. He developed CMV colitis and was then treated with maribavir. After discontinuing val(ganciclovir), genotyping revealed no resistance mutations. Following CMV DNA suppression, secondary prophylaxis with letermovir and val(ganciclovir) was initiated. Patient 2, a double-lung transplant recipient, experienced several CMV episodes. Initially treated with val(ganciclovir), he developed the L595S mutation in the UL97 kinase gene, conferring resistance. Therapy was then switched to foscarnet, which was suspended due to renal failure, and then to maribavir. Subsequently, the H411Y mutation in the UL97 was detected, conferring maribavir resistance, while val(ganciclovir) mutation was no longer detectable. He was then treated with val(ganciclovir) and letermovir, achieving undetectable CMV DNA, and then continued letermovir alone as prophylaxis. Detecting gene mutations that confer drug resistance is crucial for managing antiviral therapy when virological response is lacking. In our cases, the reversion of (va)ganciclovir-resistance mutations occurred after drug withdrawal, a previously unreported finding.
TGthe San Matteo Pavia Microbiology and Virology Working Group
the San Matteo Pavia Microbiology and Virology Working Group
+6
Background/Objectives: Bloodstream infections are among the most severe infectious diseases, with mortality rates up to 25%. Delays as short as one hour in the diagnosis or initiation of the appropriate antimicrobial therapy can significantly worsen patient outcomes. Methods: This retrospective study, in an Italian 900-bed hospital from January 2019 to December 2024, evaluates the impact of a 24/7 reorganization of the clinical microbiology laboratory, adding a night shift to ensure around-the-clock processing and introducing a fast-track diagnostic pathway to prioritize the blood cultures from critically ill patients (called urgent blood cultures) in terms of turnaround times for Gram staining, microorganism identification, and resistance marker detection. Results: A total of 194,171 blood cultures were processed. Following the implementation of the 24/7 model, the median Gram stain turnaround time decreased from 4.46 to 1.40 h, microorganism identification turnaround time decreased from 5.75 to 2.35 h, and resistance marker turnaround time from 6.97 to 2.68 h. Significant reductions were observed especially during night shifts. Urgent blood cultures yielded a higher positivity rate (16.22% vs. 13.04%) and included the isolation of time-critical bacteria that can cause meningitis, such as Streptococcus pneumoniae. Conclusions: The continuous around-the-clock processing of blood culture and prioritized blood cultures for critically ill patients significantly reduced reporting times, particularly overnight. This model enhances early sepsis management and exemplifies how tailored and precision microbiology, supported by strong interdisciplinary collaboration and effective communication, can enhance earlier targeted antimicrobial treatment.